Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
about
Anaplasma phagocytophilum: deceptively simple or simply deceptive?The role of CD8 T lymphocytes in rickettsial infectionsCloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains.Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase.Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis.Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut.Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium.Serum cytokine responses during acute human granulocytic ehrlichiosisImmunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila.Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemiaCoinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosisPrevalence of human-active and variant 1 strains of the tick-borne pathogen Anaplasma phagocytophilum in hosts and forests of eastern North AmericaExperimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosisMajor histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway.Anaplasma phagocytophilum dihydrolipoamide dehydrogenase 1 affects host-derived immunopathology during microbial colonization.Anaplasma phagocytophilum in white-tailed deerStat1 negatively regulates immune-mediated injury with Anaplasma phagocytophilum infection.Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in miceMechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.Human granulocytic anaplasmosisImmunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.Lambs immunized with an inactivated variant of Anaplasma phagocytophilum.T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infectionReceptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment.Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence.Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.Anaplasma phagocytophilum MSP4 and HSP70 Proteins Are Involved in Interactions with Host Cells during Pathogen Infection.Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice.Differential Susceptibility of Male Versus Female Laboratory Mice to Infection
P2860
Q27006742-D3D94BFA-0F1D-40DD-8EBC-649D6A0EC7FFQ27008840-AA12F5E3-3439-4DE3-B239-9227EBED5036Q32060639-F61FD0D0-28D4-4CBD-9133-9D0DF6597EC3Q33552798-66F184DC-7C86-4BD6-BFE6-CD5E7A2682E4Q33599487-C8FF6D36-99C2-4F0D-B9EF-F8769475B5ECQ33758879-91C72702-7E1A-4638-85B2-EB978CB751ACQ33962487-5B4515E9-9CF5-466C-8B24-452483CD99F1Q33995579-00C41B73-74B6-4A1C-96EB-87188EAB27E0Q33998078-5BA99241-626B-465E-92F7-865FC9CD15C8Q34003638-742AA873-17E7-47DE-959A-ED3D666CA4B9Q34003784-D8D21E5C-3FD8-4C74-9303-EE7D498B3AE2Q34007395-3EFBBEBF-F1B4-436F-B3D4-E6550D9CDF10Q34008948-7A766EFD-5807-40EA-93FA-3F2DEBC390B1Q34015928-D916DA02-374E-4397-BF29-518B4457D7FCQ34041825-085C5CBA-E739-4E21-B88F-9896D5BB61F5Q34130357-859DE773-C7B1-4441-844B-C6943F48E3F2Q34132762-29FF46FD-9759-47D0-97CA-B5F4629183D6Q34194901-942991D9-2663-4B1A-8A0E-B8887EDFE4A6Q34323818-80965C41-4D7C-4C8F-B5CE-F717601650B8Q34471500-7D0A6398-C02D-42C3-9D14-3F5744A37238Q34476289-5C9D1329-47AD-40EF-93D2-BA3E3F5EFF65Q34665901-DE61BDF7-96CB-4114-A274-B0222EC5E349Q35090150-03AF85FD-B98F-404B-9B31-AB6E73AE6663Q35638535-09A74A32-7F1B-4B41-8FCC-10D05AB55BAFQ35842136-48A5A81E-614E-4005-9262-F1B31520EBA1Q35886173-57465900-C618-4531-885D-7A5D217A6701Q36097265-3D10B5AD-AA6F-4696-9896-0C87B3B19347Q36488241-52C46604-1076-4B18-849A-702C99793157Q37381532-79A6B66B-617E-4E1D-A936-73158611D56BQ37973905-D1021496-A8CD-4E41-AEF7-747419E994E9Q39515198-959B5883-508A-4FC9-8861-885CF38CC860Q40115716-86EBD25A-DC91-4543-AF5D-9EEBCF1CF4F2Q40380529-D4D9F53E-0CAF-4E0D-BA3F-B1676BD95112Q57138947-127CE31A-37F3-4D1A-B3FB-45F712318A91
P2860
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@en
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@nl
type
label
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@en
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@nl
prefLabel
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@en
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@nl
P2093
P2860
P356
P1476
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
@en
P2093
S R Telford
S W Barthold
P2860
P304
P356
10.1172/JCI119855
P407
P577
1997-12-01T00:00:00Z